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The synthesis and biological evaluation of a series of analogues of manzamine A, representing
partial structures of the pentacyclic ABCDE diamine core, is described. All new compounds were
screened against Plasmodium falciparum and demonstrated attenuated antimalarial activity relative
to that of manzamine A.

Graphical abstract

Author Manuscript
Author Manuscript

Malaria is a disease that affects 300–500 million people each year and results annually in 1–
2 million deaths, mostly among children. Structurally and functionally novel antimalarial
agents with new mechanisms of action are needed as monotherapeutic agents and for use in
combined chemotherapy with other presently available drugs. The urgent need for new and
effective antimalarials escalates as Plasmodium falciparum and other human malaria parasite
species have developed resistance to most of the commercially available antimalarials.1 The
manzamine alkaloids represent important lead structures for the development of antiinfectives. Manzamine A and related structures are highly potent, orally bioavailable2
antimalarial agents that are more effective than most currently available therapeutics, i.e.,
chloroquine and artemisinin. In addition, some of the manzamine class have also
demonstrated activity against the AIDS-opportunistic infectious diseases including
tuberculosis and toxoplasmosis.
The isolated yield of 1 from its natural source, the Okinawan sponge Haliclona sp., was
originally reported to be 0.026% from wet sponge. The paucity of 1 from the natural source,
coupled with the length of the total syntheses reported from our laboratory and by Martin,3,4
prompted us to examine the biological activity of simplified structures based on 1. We report
herein the design, synthesis, and preliminary biological evaluation of a series of analogues of
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the pentacyclic ABCDE diamine core of manzamine A (Figure 1). The ca. 400-fold
dimunition in activity against P. faciparum for the non-β-carboline-containing manzamine
congener ircinol A (2)5 prompted us to leave the β-carboline heterocycle intact in all new
analogues.
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We prepared the B ring analogue 6 via Suzuki coupling of known boronic ester6 7 and 1bromo-β-carboline.7 The corresponding AB and BC ring analogues 5 and 4, respectively,
could be constructed in a similar manner via the Suzuki coupling of the appropriate BC and
AB boronic esters8,9 with 1-bromo-β-carboline (Scheme 1). We note that the Δ9,10 alkene in
β-carboline 10 (manzamine numbering), which results from the regiochemistry of
enolization of the ketone precursor, is regioisomeric with the Δ10,11 B-ring alkene in 1.
Completion of the synthesis of cis-AB 5a, trans-AB 5b and iso-BC 10 analogues was
achieved by Boc deprotection of the Suzuki adducts and reductive alkylation of the resulting
secondary amines with propionaldehyde.
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The preparation of the ABCE analogue 3 is based on our total synthesis of 13 and proceeds
through the tetracyclic ketone 1110 (Scheme 2). Regioselective conversion of 11 to
unsaturated ester 12 was effected via carboxylation of the enolate derived from 11 to give
the corresponding β-ketoester, followed by ketone reduction and β-elimination of the derived
mesylate. Coupling of the carboxylic acid derived from 12 with tryptamine in the presence
of BOP (Castro’s reagent) led to the formation of amide 13. Bischler–Napieralski
cyclization of 13 followed by DDQ-mediated dehydrogenation afforded the Boc-protected
ABCE analogue 14. Boc deprotection followed by reductive alkylation with
propionaldehyde afforded the ABCE tetracycle 3. The B, AB (cis and trans), iso-BC, and
ABCE analogues were then screened for activity against the W2 and D6 (chloroquineresistant) clones of P. falciparum (Table 1). Two features of these data are striking: (1) the
relatively narrow range of differences in biological activity among the new monocyclic (B),
bicyclic (AB and BC), and tetracyclic (ABCE) analogues (ca. 101) and (2) the significantly
attenuated activity of all new analogues relative to manzamine A (ca. 103). These results
suggest that partial structures of manzamine A may not serve as useful leads for the
development of new anti-infectives.
One of us has recently described the isolation of manzamine A and related substances in
significantly higher yield than originally reported, making 1 a viable starting material for the
development of new chemotherapeutic agents.11 Studies directed toward the development of
new malaria chemotherapy lead structures via functionalization of manzamine A are
currently underway in our laboratory, and our results will be reported in due course.
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Figure 1.

Analogues targeted for synthesis.

Author Manuscript
Org Lett. Author manuscript; available in PMC 2016 June 23.

Winkler et al.

Page 5

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

Scheme 1.

B, BC, and AB Ring Synthesesa
a For the preparation of 8 and 9, see footnotes 8 and 9.
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Scheme 2.

ABCE Synthesis
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Evaluation of Analogues Against P. falciparum
W2 clone IC50
(ng/mL)

D6 clone IC50
(ng/mL)

manzamine A (1)

13.5

25.0

B (6)

5550

3510

iso BC (10)

4190

920

cis AB (5a)

1270

930

trans AB (5b)

2770

1020

ABCE (14)

520

270

compound
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